0 Recommendations

Drug and Health Care Delivery: A perspective from Cambodia and Ethiopia

By Anne Goldfeld | 10 Nov, 2008

In 1994, the Cambodian Health Committee (CHC) developed a novel community-based approach to TB and later to AIDS treatment, and in April 2006 universal access for MDR treatment was started nationwide.

Following topics are covered here:
- TB in Cambodia today
- TB and HIV, and MDR TB
- Introduction to The CAMELIA: TB and HIV, linking delivery and discovery
- MDR outcomes
- Leveraging CHC to assist Ethiopia (and Vietnam)

In conclusion:

- An integrated approach of hospitalized based and community based treatment has proved highly successful in treating MDR in Cambodia

- Integrated TB/HIV services necessary for approaching MDR

- Parallel processes, such as the CHC/GHC leveraging of expertise needs to be expanded

- Greater and quicker access to MDR drugs is critical

- Large scale funding for these parallel processes is needed/ on the scale of, or a “PEPFAR-like” initiative for MDR/XDR TB necessary

Presentation given during the IOM Drug Forum Workshop: Addressing the Threat of Drug Resistant TB: A Realistic Assessment of the Challenges, held November 5, 2008 in Washington, D.C.

Attached resource:
  • Drug and Health Care Delivery: A perspective from Cambodia and Ethiopia (external URL)

    Link leads to: http://www.iom.edu/Object.File/Master/60/239/Goldfeld2_IOM_Nov5.pdf

    Summary: In 1994, the Cambodian Health Committee (CHC) developed a novel community-based approach to TB and later to AIDS treatment, and in April 2006 universal access for MDR treatment was started nationwide.

    Following topics are covered here:
    - TB in Cambodia today
    - TB and HIV, and MDR TB
    - Introduction to The CAMELIA: TB and HIV, linking delivery and discovery
    - MDR outcomes
    - Leveraging CHC to assist Ethiopia (and Vietnam)

    In conclusion:

    - An integrated approach of hospitalized based and community based treatment has proved highly successful in treating MDR in Cambodia

    - Integrated TB/HIV services necessary for approaching MDR

    - Parallel processes, such as the CHC/GHC leveraging of expertise needs to be expanded

    - Greater and quicker access to MDR drugs is critical

    - Large scale funding for these parallel processes is needed/ on the scale of, or a “PEPFAR-like” initiative for MDR/XDR TB necessary

    Presentation given during the IOM Drug Forum Workshop: Addressing the Threat of Drug Resistant TB: A Realistic Assessment of the Challenges, held November 5, 2008 in Washington, D.C.

    Source: Immune Disease Institute

    Publication Date: November 5, 2008

    Language: English

    Keywords: Cambodia, Conferences & Meetings, Ethiopia, Publications & Research, Vietnam

 

This Community is Archived.

This community is no longer active as of December 2018. Thanks to those who posted here and made this information available to others visiting the site.